Cancer continues to increase global morbidity and mortality rates. Despite substantial
progress in the development of various chemically synthesized anti-cancer drugs, the poor …

Simple Summary This review explores the challenges of drug resistance in cancer treatment
and discusses innovative strategies to overcome them. Researchers aim to understand how …

Currently, even the most effective anti-cancer therapies are often limited by the development
of drug resistance and tumor relapse, which is a major challenge facing current cancer …

The incidence of skin cancer continues to grow. There are an estimated 1.5 million new
cases each year, of which nearly 350,000 are melanoma, which is often fatal. Treatment is …

Alzheimer's disease (AD) is a progressive neurodegenerative disease that affects most
people worldwide. AD is a complex central nervous system disorder. Several drugs have …

Immunotherapy, along with chemotherapy, targeted delivery, radiation and surgery has
become one of the most common cancer treatments. The aim of cancer immunology is to …

In contrast to other types of cancers, there is no available efficient pharmacological treatment
to improve the outcomes of patients suffering from major primary liver cancers, ie …

Platinum nanoparticles are widely studied as a nanomedicine against many of the solid
tumours. Due to their promising physicochemical properties, chitosan-stabilized platinum …

Multidrug resistance (MDR) is a public health issue of particular concern, for which
nanotechnology-based multidrug delivery systems are considered among the most effective …

Multidrug resistance is a serious problem in modern medicine and the reason for the failure
of various therapies. A particularly important problem is the occurrence of multidrug …